Immunisation

There are two reasons for immunising everyone in Australia:
- Immunisation is the safest and most effective way of providing protection against childhood diseases. After immunisation, your child is far less likely to catch these diseases if there is an outbreak in the community. The benefit of protection against childhood diseases far outweighs the very small risks of immunisation
- If enough people in the community are immunised, the infection can no longer be spread from person to person and the disease dies out altogether. This is how smallpox was eliminated from the world and why polio disappeared from many countries.
Standard Vaccination Schedule
| Age | Vaccine | Brands Supplied by WA DOH | Disease Prevented |
| Birth | Hep B | H-B-Vax 11 (Paed) | Hepatitis B |
| 2 Months | 13vPCV
ORV
DTPa-IPV-HepB-Hib | Prevenar 13
Rota Teq
Infanrix Hexa | Pneumococcal
Rotavirus (Latest given at 12.9 weeks of age)
Diphtheria, Tetanus, Pertussis (Whooping cough), Poliomyelitis, Hepatitis B, and Haemophilus Influenzae type b (Meningitis) |
| 4 Months | 13vPCV
ORV
DTPa-IPV-HepB-Hib | Prevenar 13
Rota Teq
Infanrix Hexa | Pneumococcal
Rotavirus (Latest given at 28 weeks of age)
Diphtheria, Tetanus, Pertussis (Whooping cough), Poliomyelitis, Hepatitis B, and Haemophilus Influenzae type b (Meningitis) |
| 6 Months | 13vPCV
ORV
DTPa-IPV-HepB-Hib | Prevenar 13
Rota Teq
Infanrix Hexa | Pneumococcal
Rotavirus (Latest given at 32.9 weeks of age)
Diphtheria, Tetanus, Pertussis (Whooping cough), Poliomyelitis, Hepatitis B, and Haemophilus Influenzae type b (Meningitis) |
| 6 Months to < 5 Years | Flu (annual) | Vaxigrip | Influenza |
| 12 Months | MMR
Hib
MenCCV | Priorix
Hiberix
Neisvac-C | Measles, Mumps, Rubella
Haemophilus Influenzae type b (Meningitis)Meningococcal C |
Special Population: a. Aboriginal Children
b. Medically at Risk Children | Hep A
13vPCV | Vaqta
Prevenar 13 | Hepatitis A
Pneumococcal |
| 18 Months | VZV* | Varilrix | Varicella (Chicken Pox)* |
Special Population: Aboriginal Children | Hep A
13vPCV | Vaqta
Pneumovax 23 | Hepatitis A
Pneumococcal |
| 4 Years | MMR
DTPa-IPV | Priorix
Quadracel | Measles, Mumps, Rubella
Diptheria, Tetanus, Pertussis (Whooping cough) & Poliomyelitis |
Special Population:
Medically at Risk Children |
23vPPV |
Pneumovax 23 |
Pneumococcal |
| School Year 8, 9, 10 - Male Students Only
Term 1: HPV
Term 2: HPV
Term 3/4: HPV | HPV (Three doses - 0, 2 & 6 months apart)
HPV dose 1
HPV dose 2
HPV dose 3 |
Gardasil
Gardasil
Gardasil |
Human Papilloma Virus
Human Papilloma Virus
Human Papilloma Virus |
| Adults - All Aboriginal Australians aged 15-years and older;
- All individuals aged six-months and over with medical conditions predisposing to severe influenza;
- All persons 65 Years and older;
- All pregnant women;
- All individuals aged 6-months and over with medical conditions predisposing to severe influenza including cardiac disease, chronic respiratory conditions, chronic illnesses requiring regular medical follow-up or hospitalization in the preceding year, chronic neurological conditions, people with impaired immunity and children aged 6-months to 10-years receiving long term aspirin therapy
- Non-Aboriginal ≥ 65 Years, Aboriginal ≥ 50 Years, OR Aboriginal ≥ 15 Years medically at risk
| Flu (annual)
23vPPV
(one dose in total) | Fluvax, Vaxigrip, Fluarix Pneumovax | Influenza Pneumococcal |
NB: * Vaccine not required if already had the disease